精神疾病
ENGLISH ABSTRACT
无抽搐电休克疗法联合喹硫平治疗双相情感障碍躁狂发作的疗效研究
钟建炯
张利红
郑瑶
张盛杰
作者及单位信息
·
DOI: 10.3760/cma.issn1008-6706.2022.02.012
Efficacy of maintenance electroconvulsive therapy combined with quetiapine treatment for manic episode of bipolar disorder
Zhong Jianjiong
Zhang Lihong
Zheng Yao
Zhang Shengjie
Authors Info & Affiliations
Zhong Jianjiong
Department of Psychiatry, Kangci Hospital of Jiaxing, Jiaxing 314500, Zhejiang Province, China
Zhang Lihong
Department of Psychiatry, Kangci Hospital of Jiaxing, Jiaxing 314500, Zhejiang Province, China
Zheng Yao
Department of Psychiatry, Kangci Hospital of Jiaxing, Jiaxing 314500, Zhejiang Province, China
Zhang Shengjie
Department of Psychiatry, Kangci Hospital of Jiaxing, Jiaxing 314500, Zhejiang Province, China
·
DOI: 10.3760/cma.issn1008-6706.2022.02.012
2885
34
0
0
2
0
PDF下载
APP内阅读
摘要

目的探讨无抽搐电休克疗法(MECT)联合喹硫平治疗双相情感障碍躁狂发作的疗效。

方法选取嘉兴市康慈医院2019年1月至2020年8月住院治疗的双相情感障碍躁狂发作患者103例,按照抽签法分为观察组46例、对照组57例。观察组给予MECT联合喹硫平治疗,对照组给予丙戊酸镁缓释片联合喹硫平治疗,均连续治疗4周。比较两组临床疗效、住院总费用、住院药费、药占比、不良反应以及治疗前后Bech-Rafaelsen躁狂量表(BRMS)评分、威斯康星卡片分类测验(WCST)评分的变化。

结果治疗4周后,观察组总显效率为76.09%(35/46),显著高于对照组的56.14%(32/57),差异有统计学意义(χ 2=4.45, P < 0.05)。观察组住院总费用、住院药费及药占比分别为(16 074.52±1 019.81)元、(1 374.52±619.81)元、8.70%,对照组分别为(15 618.14±1 550.34)元、(1 261.14±750.34)元、10.53%,差异均无统计学意义( t=1.71、0.82,χ 2=0.09,均 P > 0.05)。观察组治疗4周后BRMS评分为(7.36±3.04)分,对照组BRMS评分为(10.23±2.37)分,差异有统计学意义( t=5.38、 P < 0.001)。观察组WCST评分中错误应答数、持续错误数分数分别为(40.45±3.61)分、(9.56±1.39)分,明显低于对照组的(48.59±4.51)分、(12.08±1.25)分;WCST评分中持续应答数为(33.85±2.50)分,明显高于对照组的(29.71±2.14)分,差异均有统计学意义( t=10.17、9.56、8.90,均 P < 0.001)。观察组、对照组不良反应总发生率分别为21.74%、22.81%,差异无统计学意义(χ 2=0.01, P >0.05)。

结论MECT联合喹硫平治疗双相情感障碍躁狂发作患者效果显著,值得临床应用。

双相情感障碍躁狂发作;无抽搐电休克疗法;丙戊酸镁缓释片;喹硫平片;Bech-Rafaelsen躁狂量表;威斯康星卡片分类测验;疗效;不良反应
ABSTRACT

ObjectiveTo investigate the efficacy of maintenance electroconvulsive therapy (MECT) combined with quetiapine treatment for manic episodes of bipolar disorder.

MethodsA total of 103 patients with manic episodes of bipolar disorder received treatment in Kangci Hospital of Jiaxing from January 2019 to August 2020 and were included in this study. They were randomly divided into observation ( n = 46) and control groups ( n = 57). The observation group was given MECT combined with quetiapine treatment and the control group was treated with magnesium valproate sustained-release tablets combined with quetiapine. All patients received 4 weeks of treatment. Clinical efficacy, total hospital cost, drug cost during hospitalization, drug proportion, adverse reactions, and scores of the Bech-Rafaelsdn Mania Rating Scale and the Wisconsin Card Sorting Test pre- and post-treatment were compared between the two groups.

ResultsAfter 4 weeks of treatment, total response rate was significantly higher in the observation group than in the control group [76.09% (35/46) vs. 56.14% (32/57), χ 2 = 4.45, P < 0.05]. In the observation group, total hospital cost, drug cost during hospitalization, and drug proportion were (16074.52 ± 1019.81) yuan, (1374.52 ± 619.81) yuan, and 8.70% respectively, which were not significantly different from those in the control group [(15618.14 ± 1550.34) yuan, (1261.14 ± 750.34) yuan, 10.53%, t = 1.71, 0.82, χ 2 = 0.09, all P > 0.05]. After 4 weeks of treatment, Bech-Rafaelsdn Mania Rating score was significantly lower in the observation group than in the control group [(7.36 ± 3.04) points vs. (10.23 ± 2.37) points, t = 5.38, P < 0.001]. The number of wrong responses and the number of perseverative errors in the Wisconsin Card Sorting Test in the observation group were (40.45 ± 3.61) counts and (9.56 ± 1.39) counts, respectively, which were significantly lower than those in the control group [(48.59 ± 4.51) counts, (12.08 ± 1.25) counts, t = 10.17, 9.56, both P < 0.001]. The number of perseverative errors in the Wisconsin Card Sorting Test was significantly higher in the observation group than in the control group [(33.85 ± 2.50) counts vs. (29.71 ± 2.14) counts, t = 8.90, P < 0.001]. There was no significant difference in total incidence of adverse reactions between observation and control groups (21.74% vs. 22.81%, χ 2 = 0.01, P > 0.05).

ConclusionMECT combined with quetiapine treatment is highly effective on the manic episodes of bipolar disorder. The combined therapy is worthy of clinical application.

Bipolar disorder manic episode;Modified electroconvulsive therapy;Magnesium valproate sustained release tablets;Quetiapine tablets;Bech rafaelsen mania scale;Wisconsin Card Sorting Test;Efficacy;Adverse reactions
Zhong Jianjiong, Email: mocdef.3ab61125gnoiqnaijgnohz
引用本文

钟建炯,张利红,郑瑶,等. 无抽搐电休克疗法联合喹硫平治疗双相情感障碍躁狂发作的疗效研究[J]. 中国基层医药,2022,29(02):212-216.

DOI:10.3760/cma.issn1008-6706.2022.02.012

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
双相情感障碍是一类既有躁狂发作或轻躁狂发作,又有抑郁发作的常见精神障碍。躁狂发作是双相情感障碍的常见发作形式,有易冲动、破坏力强等表现,有较高的肇事风险,不仅影响到自身的生活质量,也为家庭和社会均带来了较大负担 1 , 2。无抽搐电休克疗法(Modified electroconvulsive therapy,MECT)是用静脉麻醉药和肌松剂,使患者迅速入睡,全身肌肉放松,通过给人体短时间限量电流的电刺激,使人体内发生生物化学改变,从而使精神症状减轻或消失,是精神科较为常用的物理治疗手段。药物也是治疗双相情感障碍的重要环节,喹硫平是一种非特异性的抗精神病药物,对中枢神经系统的H2或D1受体可产生拮抗作用,从而起到稳定多巴胺、改善病情的效果,近年来常用于双相情感障碍的治疗 3;丙戊酸镁缓释片是一种临床上常用的广谱抗癫痫药物,其作为情感稳定剂,在治疗精神分裂症、双相情感障碍等精神疾病中具有积极作用 4。本研究旨在探讨MECT联合喹硫平片治疗双相情感障碍躁狂发作的疗效,现报告如下。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Findling RL , Stepanova E , Youngstrom EA ,et al. Progress in diagnosis and treatment of bipolar disorder among children and adolescents: an international perspective[J]. Evid Based Ment Health, 2018,21(4):177-181. DOI: 10.1136/eb-2018-102912 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
鲍爽,任燕,崔晓红,. 双相情感障碍的生物学标志物研究进展[J]. 医学综述, 2019,25(20):3991-3995,4001. DOI: 10.3969/j.issn.1006-2084.2019.20.008 .
返回引文位置Google Scholar
百度学术
万方数据
Bao S , Ren Y , Cui XH ,et al. Research Progress in Biomarkers of Bipolar Disorder[J]. Medical Recapitulate, 2019,25(20):3991-3995,4001. DOI: 10.3969/j.issn.1006-2084.2019.20.008 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[3]
郭萍,蒋军生. 碳酸锂联合喹硫平对双相情感障碍躁狂发作患者血清生化水平及认知功能的影响[J]. 中国医师杂志, 2020,22(8):1242-1244. DOI: 10.3760/cma.j.cn431274-20190614-00703 .
返回引文位置Google Scholar
百度学术
万方数据
Guo P , JIang JS . The effect of lithium carbonate combined with quetiapine on serum biochemical level and cognitive function in bipolar disorder manic patients[J]. Journal of Chinese Physician, 2020,22(8):1242-1244. DOI: 10.3760/cma.j.cn431274-20190614-00703 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[4]
Pisanu C , Heilbronner U , Squassina A . The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine[J]. Mol Diagn Ther, 2018,22(4):409-420. DOI: 10.1007/s40291-018-0335-y .
返回引文位置Google Scholar
百度学术
万方数据
[5]
美国精神医学学会. 精神障碍诊断与统计手册[M]. 北京:北京大学出版社, 2016:257-267.
American Psychiatric Association. Handbook of diagnosis and statistics of mental disorders[M]. Beijing:Peking University Press, 2016:257-267.
[6]
Teixeira AL , Colpo GD , Fries GR ,et al. Biomarkers for bipolar disorder: current status and challenges ahead[J]. Expert Rev Neurother, 2019,19(1):67-81. DOI: 10.1080/14737175.2019.1550361 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
董湘萍,尚倩倩,张芸,. 双相情感障碍患者自我效能感的相关因素研究[J]. 四川医学, 2019,40(1):47-51. DOI: 10.16252/j.cnki.issn1004-0501-2019.01.010 .
返回引文位置Google Scholar
百度学术
万方数据
Dong XP , Shang QQ , Zhang Y ,et al. Study on the related factors of self efficacy in patients with bipolar disorder[J]. Sichuan Medical Journal, 2019,40(1):47-51. DOI: 10.16252/j.cnki.issn1004-0501-2019.01.010 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[8]
Hausmann A , Post T , Post F ,et al. Efficacy of Continuation/Maintenance Electroconvulsive Therapy in the Treatment of Patients With Mood Disorders: A Retrospective Analysis[J]. J ECT, 2019,35(2):122-126. DOI: 10.1097/YCT.0000000000000547 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
Atay ÖC , Bag S , Usta H ,et al. Satisfaction and attitude of bipolar patients regarding electroconvulsive therapy: modified or unmodified[J]. Nord J Psychiatry, 2020,74(2):131-137. DOI: 10.1080/08039488.2019.1680730 .
返回引文位置Google Scholar
百度学术
万方数据
[10]
陈晓燕,曹峰. 无抽搐电休克疗法联合丙戊酸钠缓释片对双相情感障碍躁狂发作患者认知功能及预后的影响[J]. 中国基层医药, 2020,27(9):1040-1045. DOI: 10.3760/cma.j.issn.1008-6706.2020.09.004 .
返回引文位置Google Scholar
百度学术
万方数据
Chen XY , Cao F . Effects of non-convulsive electroconvulsive therapy combined with sodium valproate sustained-release tablets on cognitive function and prognosis of bipolar disorder patients with manic episode[J]. Chin J Prim Med Pharm, 2020,27(9):1040-1045. DOI: 10.3760/cma.j.issn.1008-6706.2020.09.004 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[11]
马淑君,陈璨,纪晓斌,. 喹硫平治疗双相情感障碍的效果观察[J]. 国际精神病学杂志, 2020,47(1):55-57.
返回引文位置Google Scholar
百度学术
万方数据
Ma SJ , Chen C , Ji XB ,et al. Clinical observation of quetiapine in the treatment of bipolar disorder[J]. Journal of International Psychiatry, 2020,47(1):55-57.
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[12]
Yatham LN , Kennedy SH , Parikh SV ,et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder[J]. Bipolar Disord, 2018,20(2):97-170. DOI: 10.1111/bdi.12609 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
李芳,范悦斌,张育芬,. 碳酸锂联合富马酸喹硫平片或丙戊酸镁缓释片治疗双相情感障碍躁狂发作的疗效[J]. 国际精神病学杂志, 2019,46(1):81-83,95.
返回引文位置Google Scholar
百度学术
万方数据
Li F , Fan YB , Zhang YF ,et al. The effect of quetiapine fumarate and magnesium valproate sustained release tablets combined with lithium carbonate in patients with manic attack of bipolar disorder[J]. Journal of International Psychiatry, 2019,46(1):81-83,95.
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[14]
左洋,王明涛,吴迎春. 基于生物心理社会医学探析G-CBT配合丙戊酸镁缓释片对双相情感障碍的价值[J]. 精神医学杂志, 2020,33(1):37-40. DOI: 10.3969/j.issn.2095-9346.2020.01.009 .
返回引文位置Google Scholar
百度学术
万方数据
Zuo Y , Wang MT , Wu YC . An analysis of the value of G-CBT combined with magnesium valproate sustained-release tablets in bipolar disorder based on bio-psycho-social medical model[J]. Journal of Psychiatry, 2020,33(1):37-40. DOI: 10.3969/j.issn.2095-9346.2020.01.009 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
[15]
Anmella G , Pacchiarotti I , Cubała WJ ,et al. Expert advice on the management of valproate in women with bipolar disorder at childbearing age[J]. Eur Neuropsychopharmacol, 2019,29(11):1199-1212. DOI: 10.1016/j.euroneuro.2019.09.007 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
庞蓉,潘梅. 喹硫平联合丙戊酸镁治疗双相情感障碍对患者生活质量的影响情况研究[J]. 湖南师范大学学报:医学版, 2019,16(4):115-117. DOI: 10.3969/j.issn.1673-016X.2019.04.038 .
返回引文位置Google Scholar
百度学术
万方数据
Pang R , Pan M . Effect of quetiapine combined with magnesium valproate on the quality of life of patients with bipolar disorder[J]. Journal of Hunan Normal University:Medical Science, 2019,16(4):115-117. DOI: 10.3969/j.issn.1673-016X.2019.04.038 .
Goto CitationGoogle Scholar
Baidu Scholar
Wanfang Data
备注信息
A
钟建炯,Email: mocdef.3ab61125gnoiqnaijgnohz
B

钟建炯:酝酿和设计实验、实施研究、采集数据、分析/解释数据、起草文章、对文章的知识性内容作批评性审阅、统计分析;张利红:资料收集与整理;郑瑶:统计分析;张盛杰:文章的写作构思与数据统计分析

C

钟建炯, 张利红, 郑瑶, 等. 无抽搐电休克疗法联合喹硫平治疗双相情感障碍躁狂发作的疗效研究[J]. 中国基层医药, 2022, 29(2): 212-216. DOI: 10.3760/cma.issn1008-6706.2022.02.012.

D
所有作者声明无利益冲突
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号